Picture of Champions Oncology logo

CSBR Champions Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Champions Oncology Inc reports results for the quarter ended in July - Earnings Summary

* Champions Oncology Inc  CSBR.OQ  reported a quarterly adjusted
loss of 1 cents​​ per share for the quarter ended in July. The
mean expectation of two analysts for the quarter was
for earnings of one cents per share.
* Revenue rose 17.9% to $11.25 million from a year ago; 
analysts expected $10.98 million. 
* Champions Oncology Inc's reported EPS for the quarter was a
loss of 1 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Champions Oncology Inc shares had fallen by 2.7% this
quarter and lost 7.3% so far this year.
* The company reported a quarterly loss of $172 thousand.
* Wall Street's median 12-month price target for Champions
Oncology Inc is $16.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated September 13 at 09:48 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Champions Oncology

See all news